ReP USP - Resultado da busca

Artigo de periodico
The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro (2020)
Jacomasso, Thiago; Ribas, Hennrique Taborda; Lima, Marina Trombetta ; Konig, Michelle Silberspitz; Trindade, Edvaldo da Silva; Martinez, Glaucia Regina ; Sogayar, Mari Cleide ; Winnischofer, Sheila Maria Brochado
Source: Melanoma Research. Unidade: IQ
Subjects: MELANOMA, EXPRESSÃO GÊNICA, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOMASSO, Thiago et al. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, v. 30, n. 3, p. 223-234, 2020Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000650. Acesso em: 15 out. 2024.
APA
Jacomasso, T., Ribas, H. T., Lima, M. T., Konig, M. S., Trindade, E. da S., Martinez, G. R., et al. (2020). The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro. Melanoma Research, 30( 3), 223-234. doi:10.1097/CMR.0000000000000650
NLM
Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000650
Vancouver
Jacomasso T, Ribas HT, Lima MT, Konig MS, Trindade E da S, Martinez GR, Sogayar MC, Winnischofer SMB. The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro [Internet]. Melanoma Research. 2020 ; 30( 3): 223-234.[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000650
Artigo de periodico
LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis (2015)
Araújo, Érica S.S. de; Kashiwabara, André Y.; Achatz, Maria I.W.; Moredo, Luciana F.; De Sa, Bianca C.S.; Duprat, Joao P.; Rosenberg, Carla ; Carraro, Dirce M; Krepischi, Ana Cristina Victorino
Source: Melanoma Research. Unidade: IB
Subjects: MUTAÇÃO GENÉTICA, MELANOMA, NEOPLASIAS (GENÉTICA), LEUCÓCITOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAÚJO, Érica S.S. de et al. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis. Melanoma Research, 2015Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000141. Acesso em: 15 out. 2024.
APA
Araújo, É. S. S. de, Kashiwabara, A. Y., Achatz, M. I. W., Moredo, L. F., De Sa, B. C. S., Duprat, J. P., et al. (2015). LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis. Melanoma Research. doi:10.1097/CMR.0000000000000141
NLM
Araújo ÉSS de, Kashiwabara AY, Achatz MIW, Moredo LF, De Sa BCS, Duprat JP, Rosenberg C, Carraro DM, Krepischi ACV. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis [Internet]. Melanoma Research. 2015 ;[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000141
Vancouver
Araújo ÉSS de, Kashiwabara AY, Achatz MIW, Moredo LF, De Sa BCS, Duprat JP, Rosenberg C, Carraro DM, Krepischi ACV. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis [Internet]. Melanoma Research. 2015 ;[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000141
Artigo de periodico
Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2 (2014)
Jacomasso, Thiago; Trombetta-Lima, Marina; Sogayar, Mari Cleide ; Winnischofer, Sheila Maria Brochado
Source: Melanoma Research. Unidade: IQ
Subjects: MELANOMA, METALOPROTEINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JACOMASSO, Thiago et al. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2. Melanoma Research, v. 24, n. 1, p. 32-39, 2014Tradução . . Disponível em: https://doi.org/10.1097/CMR.0000000000000039. Acesso em: 15 out. 2024.
APA
Jacomasso, T., Trombetta-Lima, M., Sogayar, M. C., & Winnischofer, S. M. B. (2014). Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2. Melanoma Research, 24( 1), 32-39. doi:10.1097/CMR.0000000000000039
NLM
Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SMB. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2 [Internet]. Melanoma Research. 2014 ; 24( 1): 32-39.[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000039
Vancouver
Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SMB. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2 [Internet]. Melanoma Research. 2014 ; 24( 1): 32-39.[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/CMR.0000000000000039
Artigo de periodico
Mid-humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma (2010)
Teixeira, Frederico; Akaishi, Eduardo; Mendes, Gabriella; Moutinho, Vitor; Utiyama, Edivaldo; Rasslan, Samir
Source: Melanoma Research. Unidade: FM
Subjects: MELANOMA, NEOPLASIAS CUTÂNEAS, GÂNGLIOS LINFÁTICOS, DISSECÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA, Frederico et al. Mid-humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma. Melanoma Research, v. 20, n. 2, p. 138-140, 2010Tradução . . Disponível em: https://doi.org/10.1097/cmr.0b013e328335053c. Acesso em: 15 out. 2024.
APA
Teixeira, F., Akaishi, E., Mendes, G., Moutinho, V., Utiyama, E., & Rasslan, S. (2010). Mid-humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma. Melanoma Research, 20( 2), 138-140. doi:10.1097/cmr.0b013e328335053c
NLM
Teixeira F, Akaishi E, Mendes G, Moutinho V, Utiyama E, Rasslan S. Mid-humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma [Internet]. Melanoma Research. 2010 ; 20( 2): 138-140.[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/cmr.0b013e328335053c
Vancouver
Teixeira F, Akaishi E, Mendes G, Moutinho V, Utiyama E, Rasslan S. Mid-humeral sentinel lymph node dissection in patients with primary cutaneous malignant melanoma [Internet]. Melanoma Research. 2010 ; 20( 2): 138-140.[citado 2024 out. 15 ] Available from: https://doi.org/10.1097/cmr.0b013e328335053c

USP Schools

ReP

Filtros

Authors

Subjects

Non normalized affiliation